{"id":"https://openalex.org/W2273307992","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.tps283","title":"A phase II trial of oral panobinostat (LBH589), a novel deacetylase inhibitor (DACi) in patients with primary myelofibrosis (PMF), post-essential thrombocythemia (ET) myelofibrosis, and post-polycythemia vera (PV) myelofibrosis.","display_name":"A phase II trial of oral panobinostat (LBH589), a novel deacetylase inhibitor (DACi) in patients with primary myelofibrosis (PMF), post-essential thrombocythemia (ET) myelofibrosis, and post-polycythemia vera (PV) myelofibrosis.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2273307992","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.tps283","mag":"2273307992"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.tps283","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.tps283","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.tps283","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. J. DeAngelo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016216479","display_name":"Ayalew Tefferi","orcid":"https://orcid.org/0000-0003-4605-3821","observed_orcids":["https://orcid.org/0000-0003-4605-3821"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Tefferi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. A. Mesa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027170576","display_name":"Carole S. Paley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. S. Paley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047939331","display_name":"Martha Wadleigh","orcid":"https://orcid.org/0000-0002-8191-1708","observed_orcids":["https://orcid.org/0000-0002-8191-1708"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Wadleigh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070337494","display_name":"DS Snyder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Snyder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113803344","display_name":"Michael S. Ondovik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. S. Ondovik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013510024","display_name":"Jessica Rine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Rine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5079069209","display_name":"Kapil N. Bhalla","orcid":"https://orcid.org/0000-0001-5209-5126","observed_orcids":["https://orcid.org/0000-0001-5209-5126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. N. Bhalla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"TPS283","last_page":"TPS283"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/panobinostat","display_name":"panobinostat","score":0.9959999918937683},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9240000247955322},{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":0.8230000138282776},{"id":"https://openalex.org/keywords/post-essential-thrombocythemia-myelofibrosis","display_name":"post-essential thrombocythemia myelofibrosis","score":0.9399999976158142},{"id":"https://openalex.org/keywords/post-polycythemia-vera-myelofibrosis","display_name":"post-polycythemia vera myelofibrosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/deacetylase-inhibitors","display_name":"deacetylase inhibitors","score":0.7919999957084656},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.8579999804496765},{"id":"https://openalex.org/keywords/mpn","display_name":"MPN","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9048597812652588},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.8345751166343689},{"id":"https://openalex.org/C2780225316","wikidata":"https://www.wikidata.org/wiki/Q7131441","display_name":"Panobinostat","level":5,"score":0.8154017925262451},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.6262686252593994},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.5932059288024902},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5869434475898743},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5609315633773804},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.5047444105148315},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.494009792804718},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4765230417251587},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.448337584733963},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4105910360813141},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3342271149158478},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.29557889699935913},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.15257561206817627},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.tps283","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.tps283","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.tps283","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2549591113","https://openalex.org/W2547095534","https://openalex.org/W2025124131","https://openalex.org/W1981888767","https://openalex.org/W2563510572","https://openalex.org/W2526566591","https://openalex.org/W2559167331","https://openalex.org/W64522295","https://openalex.org/W768971023","https://openalex.org/W2615349975"],"abstract_inverted_index":{"TPS283":[0],"Background:":[1],"Medical":[2],"treatment":[3,54],"options":[4],"for":[5,108,209],"myelofibrosis":[6],"(MF)":[7],"are":[8,20,23,172,217,259,265],"palliative":[9],"in":[10,74,96,136,219,256,286],"nature.":[11],"Short":[12],"of":[13,48,61,94,130,154,193,224,230,254,271,284,296],"allogeneic":[14],"stem":[15],"cell":[16],"transplantation,":[17],"no":[18,215],"therapies":[19],"available":[21],"that":[22,38,53],"curative":[24],"or":[25,156,170,185,308,312],"confer":[26],"a":[27,34,41,89,118,133,205],"survival":[28],"benefit.":[29],"Panobinostat":[30],"(PAN;":[31],"LBH589)":[32],"is":[33,204,242],"potent":[35],"pan-deacetylase":[36],"inhibitor":[37],"belongs":[39],"to":[40,125,237,262],"structurally":[42],"novel":[43],"cinnamic":[44],"hydroxamic":[45],"acid":[46],"class":[47],"compounds.":[49],"Preclinical":[50],"studies":[51],"demonstrated":[52,112],"with":[55,84,98,105,138,143,159],"PAN":[56,95,131,177,285],"alone":[57],"depletes":[58],"the":[59,128,166,220,232,268,275],"levels":[60],"JAK2V617F":[62],"(JAK2)":[63],"and":[64,69,72,247,280,282],"signaling":[65],"downstream":[66],"through":[67],"STAT3":[68],"5,":[70],"AKT,":[71],"c-RAF/MAPK":[73],"human":[75],"MPN":[76],"progenitor":[77],"cells,":[78],"including":[79],"those":[80,263],"from":[81],"patients":[82],"(pts)":[83],"MF":[85,106,147,152,272,287],"(Blood":[86],"2009;114:5024).":[87],"In":[88],"prior":[90],"phase":[91,119],"IA/II":[92],"study":[93,124,203],"pts":[97,104,111,137,142,195,223,257,273,301],"advanced":[99],"hematologic":[100],"malignancies,":[101],"among":[102],"12":[103],"evaluable":[107],"response,":[109],"4":[110],"durable":[113],"clinical":[114,248],"improvement.":[115],"We":[116],"present":[117],"II,":[120],"multicenter,":[121],"open-label,":[122],"2-stage":[123],"further":[126,238],"evaluate":[127],"efficacy":[129],"as":[132],"single":[134],"agent":[135],"MF.":[139],"Methods:":[140],"Adult":[141],"PMF,":[144],"post":[145],"ET/PV":[146],"who":[148,258,264],"have":[149,302],"an":[150],"IPSS-":[151],"score":[153],"2":[155,191],"3":[157],"along":[158],"either":[160,225],"symptomatic":[161,269],"splenomegaly":[162],"(>10":[163],"cm":[164],"below":[165],"costal":[167],"margin":[168],"[BCM])":[169],"anemia,":[171],"eligible.":[173],"Pts":[174],"will":[175,189,234],"receive":[176],"orally":[178],"40":[179],"mg":[180],"TIW":[181],"until":[182],"disease":[183],"progression":[184],"unacceptable":[186],"toxicity.":[187],"There":[188],"be":[190,235],"cohorts":[192],"20":[194,199],"(20":[196],"JAK2":[197,200,260,266],"mutated,":[198],"wild-type).":[201],"The":[202],"2-":[206],"stage":[207],"trial":[208],"each":[210],"independently":[211],"powered":[212],"cohort.":[213],"If":[214],"responses":[216,255],"seen":[218],"first":[221],"13":[222],"cohort":[226,233],"within":[227],"6":[228],"cycles":[229],"treatment,":[231],"closed":[236],"accrual.":[239],"Primary":[240],"endpoint":[241],"overall":[243],"response":[244],"(CR,":[245],"PR,":[246],"improvement).":[249],"Secondary":[250],"endpoints":[251,290],"include":[252,291],"comparison":[253],"mutated":[261],"wild-type;":[267],"improvement":[270],"using":[274],"Myelofibrosis":[276],"Symptom":[277],"Assessment":[278],"Form,":[279],"safety":[281],"tolerability":[283],"pts.":[288],"Exploratory":[289],"correlative":[292],"biomarker":[293],"studies.":[294],"As":[295],"January":[297],"12,":[298],"2010,":[299],"8":[300],"been":[303],"enrolled.":[304],"Author":[305],"Disclosure":[306],"Employment":[307],"Leadership":[309],"Position":[310],"Consultant":[311],"Advisory":[313],"Role":[314],"Stock":[315],"Ownership":[316],"Honoraria":[317],"Research":[318],"Funding":[319],"Expert":[320],"Testimony":[321],"Other":[322],"Remuneration":[323],"Novartis":[324,325,326,327,328]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}